Interleukin-1 inhibition and fatigue in primary Sjögren's syndrome--a double blind, randomised clinical trial.

PLoS One · 2012 · PMC3254637 · PMID 22253903

Europe PMC DOI

hedged sentences

0.0050

closest p · 0.1× alpha

0.0050

boldest claim

The sentences

highly significantp = 0.005actually significant

almost significantp = 0.053so close (0.05 < p ≤ 0.1)

There was a highly significant improvement in fatigue at week 4, compared to baseline, in the group on the active drug (p = 0.005), and an almost significant improvement in the placebo treated group, p = 0.053 (Friedman Test), Figure 2 .

also in 132,142 other papers

close to significanceno p-value reported

The placebo effect was quite strong in this study, as both groups had a reduction in fatigue at week 2 close to significance.

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.